Evidence map›Paper›PMID 30702173›Full record

Trial reportHead & neck2019

Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer.

Sebastian Strieth, Benjamin P Ernst, Ina Both, Daniel Hirth, Lara N Pfisterer, Julian Künzel, Katharina Eder

Open access · hybridAbstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Head & neck, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Is COLasers in medical science · 2023
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Identification of core miRNA prognostic markers in patients with laryngeal cancer using bioinformatics analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sebastian StriethDepartment of Otorhinolaryngology-Section of Head and Neck Surgery, Goethe-University Medical Center, Frankfurt/Main, Germany.ORCID 0000-0003-0177-1926
Benjamin P ErnstDepartment of Otorhinolaryngology-Section of Head and Neck Surgery, Goethe-University Medical Center, Frankfurt/Main, Germany.
Ina BothDepartment of Otorhinolaryngology-Section of Head and Neck Surgery, Goethe-University Medical Center, Frankfurt/Main, Germany.
Daniel HirthDepartment of Otorhinolaryngology-Section of Phoniatrics, Goethe-University Medical Center, Frankfurt/Main, Germany.
Lara N PfistererDepartment of Otorhinolaryngology-Section of Phoniatrics, Goethe-University Medical Center, Frankfurt/Main, Germany.
Julian KünzelDepartment of Otorhinolaryngology-Head and Neck Surgery, Johannes Gutenberg-University Medical Center, Mainz, Germany.
Katharina EderDepartment of Otorhinolaryngology-Section of Phoniatrics, Ludwig-Maximilians-University Medical Center, Munich, Germany.
Goethe University Frankfurt · DEJohannes Gutenberg University Mainz · DELudwig-Maximilians-Universität München · DE

Funding

Comprehensive University Cancer Center (UCT) of ꁬGoethe-University, Frankfurt/Main, Germany
6 · The paper itself

Abstract

backgroundLocal control rate (LCR) of early glottic cancer is high after radiation therapy or transoral laser microsurgery (TLM). The aim of this study was to investigate functional voice outcome after TLM using a microvessel-ablative potassium-titanyl-phosphate (KTP) laser in comparison with a gold standard cutting CO

methodsThe primary end point of this prospective, randomized, single-blinded, clinical phase II study with control group was voice outcome during a follow-up of 6 months assayed by Voice Handicap Index (VHI-30)-questionnaires in patients with unilateral high-grade dysplasia, carcinoma in situ or early glottic cancer undergoing TLM-KTP (n = 8) or TLM-CO

resultsStarting from the 9-week-follow-up visit, TLM-KTP yielded significantly reduced VHI scores compared to TLM-CO

conclusionMulticenter phase II or III studies on voice outcome or local control rate after TLM-KTP in early glottic cancer are warranted enrolling larger patient cohorts.

Indexed as

AgedAged, 80 and overCarcinoma, Squamous CellEarly Detection of CancerFemaleFollow-Up StudiesHumansLaryngeal NeoplasmsLasers, GasLasers, Solid-StateLaser TherapyMaleMicrosurgeryMiddle AgedNeoplasm InvasivenessNeoplasm Stagingangiolytic therapyCO2 laserlocal control rateT1 glottic cancerVoice Handicap Index (VHI-30)

Identifiers

PMID30702173
PMCPMC6972647
OpenAlexW2914570413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.